UCB Invests in Atlanta Manufacturing; Florida EXTENDS HIV Med Access
Belgian pharmaceutical firm UCB is set to invest $2 billion in a new manufacturing facility in suburban Atlanta, underscoring its commitment to the U.S. market. The new facility is expected to create approximately 330 jobs, serving as a vital component of UCB's strategy to enhance drug distribution in America. UCB's CEO Jean-Christophe Tellier expressed optimism about these growth prospects, highlighting the importance of the U.S. market.
In Florida, access to critical HIV medication for low-income residents has been extended through new legislation signed by Governor Ron DeSantis. This law provides an additional three-month extension to the state's AIDS Drug Assistance Program, ensuring ongoing support for those in need.
The FDA has issued a cautionary warning to ImmunityBio Inc. over potentially misleading claims made by Dr. Patrick Soon-Shiong regarding Anktiva, a drug developed primarily for bladder cancer. The federal agency acted against promotional content suggesting the drug's efficacy for other cancers without sufficient evidence.
In a recent development, CVS Health's Caremark division reached a settlement with the FTC regarding a lawsuit over insulin pricing practices. While details remain largely undisclosed, this settlement aligns with a similar agreement recently secured with Express Scripts, showcasing a broader approach to regulatory compliance in drug pricing.
A new analysis indicates that pharmaceutical companies have faced minimal financial penalties for kickback practices connected to drug sales, with fines amounting to merely 2.2% of revenue over the past 25 years. This highlights a significant compliance challenge within the pharmaceutical sector.
CommonSpirit and Humana have renewed their agreement, extending Medicare Advantage access for Humana's members within CommonSpirit's healthcare network for three years. The agreement restores coverage for patients in Colorado and Texas, following a temporary lapse in regional contracts.
Highmark Health reported a decline in annual earnings amid increased healthcare utilization. The organization attributes the strain to deferred medical care from the pandemic and changing demographics. CEO David Holmberg emphasized rising healthcare costs as a continuing concern for the industry.
UCI Health plans to cut roughly 150 jobs, representing 1% of its workforce, as a strategic response to shifts in federal funding and insurance reimbursement rates. This reduction aims to better align with current financial realities.
Oura, a technology company known for its health-monitoring smart ring, continues to expand its offerings, driven by significant capital raised to boost growth in the healthcare technology sector. The smart ring, popular since 2015, advances the company's presence in health metric tracking.